Jian Xie - Dec 31, 2023 Form 5 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role
President and COO
Signature
/s/ Paul Kim as Attorney-in-Fact
Stock symbol
FLGT
Transactions as of
Dec 31, 2023
Transactions value $
-$1,044,807
Form type
5
Date filed
2/9/2024, 06:09 PM
Previous filing
Dec 13, 2023
Next filing
Jan 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLGT Common Stock Sale -$465K -4.3K -1.18% $108.22 359K Mar 10, 2021 Direct F1, F2
transaction FLGT Common Stock Sale -$579K -5.7K -1.59% $101.66 353K Mar 11, 2021 Direct F3, F4
holding FLGT Common Stock 221K Dec 31, 2023 By Trust F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale of the shares occured in the fiscal year ended December 31, 2021, but the filing of the Form 4 was inadvertently missed during that period.
F2 The shares were sold in multiple transactions at prices ranging from $103.92 to $112.00, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission (the "SEC") staff, Fulgent Genetics, Inc. (the "Issuer") or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 The sale of the shares occured in the fiscal year ended December 31, 2021, but the filing of the Form 4 was inadvertently missed during that period.
F4 The shares were sold in multiple transactions at prices ranging from $100.28 to $104.09, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F5 Securities held by The Hsieh Family Dynasty Trust, dated January 27, 2010 (the "Trust"). Mr. Xie serves on the investment committee of the Trust. Mr. Xie disclaims any beneficial interest except with respect to any pecuniary interest therein.